Yourgene Health Plc, a molecular diagnostic company, researches, develops, and commercializes gene analysis techniques for prenatal screening and other applications in the United Kingdom and internationally. The company develops the IONA Test, an in vitro diagnostic non-invasive pre-natal test (NIPT) screening for pregnant women to estimate Down's syndrome, Edward's syndrome, and Patau's syndrome. The IONA test enables clinical laboratories to perform their own NIPT screening service. It also offers Cystic Fibrosis screening test; genetic disease screening products; and reproductive health products, which include polymerase chain reaction -based screening tests for male factor infertility, recurrent pregnancy loss, and genetic thrombosis. The company was formerly known as Premaitha Health PLC and changed its name to Yourgene Health Plc in November 2018. The company was incorporated in 2000 and is headquartered in Manchester, the United Kingdom. The company trades on AIM exchange marketplace. The company headquarter is located in United Kingdom. The company was established in the 2014. As of writing, the company status seems to be inactive, which indicates it may not be actively trading on the stock exchanges and may be delisted/merged/suspended/renamed.
TickerYGEN
Long NameYourgene Health PLC
Short NameYourgene Health
SectorHealthcare
SubsectorDiagnostics & Research
Subsector 2Health Care
CurrencyGBX
ISIN